The SCID (severe combined immunodeficiency) mouse model may represent a useful tool to improve our understanding of B cell lymphomagenesis in man. When peripheral blood mononuclear cells (PBMC) from Epstein-Barr-Virus seropositive (EBV +) human donors are transferred into these animals, the mice develop EBV + lymphomas of human B cell origin that closely recall immunoblastic lymphomas frequently observed in immunocompromised patients. As increased urinary levels of neopterin are commonly observed in patients with B cell lymphomas, we wondered whether neopterin would also be detected in the SCID model. Neopterin levels were evaluated by HPLC and RIA (Henning, Germany) in urinary samples from non-injected, PBMC-injected, and lymphoblastoid cell line (LCL) cell-injected SCID mice at different intervals following inoculation. Neopterin was undetectable in the urine of 19/20 untreated animals. Negative results w~re also obtained in LCL cell-injected SCID mice.
In contrast, neopterin was detected in 4/4 animals (1.3-2.5 umol/l) injected with unfractionated PBMC as early as 7 days post-inoculation, and plateaued between 2 and 3 weeks later; levels slowly declined thereafter, and neopterin was no longer detectable 7 weeks after cell transfer, when tumours began to develop. In agreement with earlier studies, normal mice did not excrete detectable amounts of neopterin. Also mice injected with LCL cells had no detectable neopterin excretion indicating that the tumour cells themselves do not release significant amounts of neopterin, whereas SCID mice reconstituted with human PBMC excrete neopterin which is therefore likely to be released from the injected human monocyte/ macrophage population. B-cell lymphoma cell injection into SCID mice is associated with intense cell activation, as shown by the early appearance of high (1-10 mg/ml) human Ig levels in mouse serum. Since neopterin is a major macrophage product, and B cell lymphomas are associated with high neopterin levels in man, our observations feature the importance of immune activation in the pathogenesis of these malignancies. Immune activation was found to be a strict requirement for lymphomagenesis in the PBMC-injected SCID model. Although neopterin levels do not seem to be a strict index of tumor development, follow-up of urinary neopterin could constitute a useful tool for monitoring PBMe take in this experimental model. In earlier studies we have shown that urine neopterin concentrations were stable for at least 24 hours after death, whereas serum neopterin concentrations increase with time after death. Serum and urine neopterin concentrations were higher in cases with inflammatory disorders compared to those without In the present study we investigated concentrations of neopterin, tryptophan, kynurenine and 5-hydroxyindoleacetic acid (HIAA) in cerebrospinal fluid (CSF) is corpses. Because of the biochemical background, neopterin and tryptophan metabolism may serve as candidate parameters to detect associations between immune system alterations and neurotransmitter abnormalities. CSF samples were taken from 64 corpses (41 male, 23 female; mean age 60 years; 5 months-91 years). Eight were suicides and 56 nonsuicides; 27 were with and 37 without signs of inflammatory disorders. CSF samples were taken during autopsy after brain cavity was opened and cerebrum was separated from midbraine. CSF neopterin, tryptophan and kynurenine was measured by HPLC, HIAA by fluorescence-polarisation-immunoassay and CSF protein according to Bradford. Average neopterin and tryptophan concentrations were considerably higher in corpses compared to the upper normal limit in CSF of healthy controls obtained via lumbal puncture. Kynurenine. which is undetectable in CSF of healthy individuals. was detectable in more than 50% of samples. In the majority of cases HIAA was not different from alive controls. CSF protein was elevated in most cases (median: 1.7 gil). There were significant correlations between neopterin and kynurenine and between tryptophan and kynurenine but there was no dependency from time after death.
Kynurenine concentrations were higher in corpses with inflammatory disorders compared to those without. No significant differences in the concentrations of analytes were seen comparing suicides and non-suicides.
The reason for high neopterin and kynurenine levels compared to halthy controls is not clear. Since there was a significant association between neopterin and kynurenine concentrations, the data suggest that imPteridines / Vol. 4 / No.2 mune mediated pathways are involved in the formation of neopterin and kynurenine concentrations in cerebrospinal fluid postmortem, which could probably involve development of hypoxia after death.
Isoxanthopterin, the Forgotten Pterin
Anderson D, Blair JA, Hodgkins P Pharmaceutical Sciences, Aston University, Birmingham Isoxanthopterin is present in normal human urines in amounts similar to total neopterins and bipterins. Its measurement can be used to show (a) methotrexate stimulated serum biopterins increase is due to dihydrofolate reductase inhibition and not to dihydropteridine reductase inhibition, (b) reduced tetrahydrobiopterin turnover in severe depression and (c) reduced tetrahydrobiopterin turnover in Down's syndrome.
An Update on Depression
Anderson DN, Blair JA, Hodgkins P Pharmaceutical Sciences, Aston University, Birmingham Synopsis Urinary excretion of neopterins and biopterins was measured in 23 patients with severe depression before and after receiving electroconvulsive therapy (ECT) and 26 healthy control supjects. Patients with psychotic depression and those responding to ECT had neopterin: biopterin (N :B) ratio significantly higher than controls before commencing ECT and positive therapeutic response was associated with reduction of N:B ratio towards control values. As a raised N:B radio implies failure to convert neopterin to biopterin it is possible that reduced availability of tetrahydro-biopterin, the essential cofactor for the formation of noradrenaline. serotonin and dopamine, may exert rate limiting controls over the synthesis of monoamines implicated in the pathogenesis of depressive disorders. The N:B ratio may be a marker for certain depressive subtypes and response to ECT. The course of malignant diseases is often associated with disturbed zinc metabolism. Recent data indicate that endogenous cytokines are able to impair renal tubular zinc reabsorption which could be the reason for enhanced urinary zinc excretion.
In 52 patients with gynaecological cancer we compared urinary zinc concentrations (measured by flame absorption spectrophotometry), with urinary neopterin levels (determined by HPLC) which indicate the degree of immune activation in patients.
19 patients with progressive disease had significantly elevated zinc (mean± S.D.: 3.47± 4.66 mmol/mol creatinine) and neopterin (477± 483 Ilmol/mol creatinine) levels compared to 9 healthy controls (zinc: 0.93± 0.62, neopterin: l25± 42) and to 12 patients with stable disease (zinc: 1.40± 0.69; neopterin: 196± 61) and 21 patients who had no evidence of disease (zinc: 1.20± 0.60; neopterin: correlation existed between neopterin and zinc levels (r, =0.591. p<0.012) in patients with progressive disease.
From the data we conclude that zinc metabolism is impaired in patients with gynaecological cancer. Immune system' activation may be involved in abnormalities of zinc metabolism in patients. Previous studies have shown that serum concentrations of neopterin are significantly increased in burned patients, but no clear relationship between neopterin production and excretion has bcen established in infected burned patients. We have measured serum neopterin and urinary neopterin excretion in more than 250 burned patients. Neopterin was measured in 24 hours urine samples (24-hr) and corresponding serum samples by High Pressure Liquid Chromatography once a week during the postburn recovery period. Since renal impairment influences both serum and urine neopterin by altering excretion, samples were screened to exclude specimens from patients with creatinine clearances of less than 50 ml/min. Both mean serum neopterin concentration and 24-hr neopterin excretion were similar to those of unburned controls during the first postburn week. Mean serum concentration and 24-hr excretion increased to about 4 times unburned control levels by postburn weeks 5 and 3 respectively. This increased neopterin production was accompanied by an apparent increase in renal tubular secretion of neopterin. Levels of neopterin from samples taken within 5 days before or after diagnosis of bacteremia or pneumonia showed no difference in serum neopterin concentration, but a decrease in 24-hr neopterin excretion, compared to samples from patients who experienced no infection. We conclude that pneumonia or bacteremia suppress the increased production and/or tubular excretion of neopterin that occurs in burned patients.
Serum Neopterin Concentration and Excretion in

Tetrahydrobiopterin in Down Syndrome
Cattel R, Praher V, Armstrong R, Blair JA Pharmaceutical Sciences, Aston University, Birmingham Tetrahydrobiopterin synthesis is reduced in Down syndrom as measured by (a) a persistently high urine neopterin biopterin ratio during life, (b) a reduced urine isoxanthopterin output and (c) a delayed PlOO visual evoked response.
weight loss within the past six months. Patients suffered from non-Hodgkin's lymphoma (n=35), Hodgkin's disease (n= 10) and multiple myeloma (n=5). Serum sTNFR-55 was measured by ELIBA, and serum neopterin was quantified by RIA (Henning, Berlin, Germany). Compared to healthy controls and to patients with potential thyroid disease, significantly elevated concentrations of sTNF-R55 were found (mean± SE: 2.68± 0.22 ng/ml vs. 1.23± 0.21 ng/mt, p<O.OOOI and 2.l8± 0.32 ng/ml, p=O.03). Likewise, neopterin concentrations were raised (l9.6± 3.66 nmol/l vs 5.3± 0.25 nmol/l in controls, p<O.OOOI). We found a significant correlation between sTNF-R55 and neopterin concentrations (rs=0.544, p< 0.(01). Patients with weight loss showed higher sTNF-R55 concentrations than patients with stable weight. Our results confirm the i-elevance of sTNF-R55 concentrations in serum of patients with cancer. The strong association with signs of immune activation argues in favour of the assumption that sTNFRs are mainly produced by cells of the immune system. The correlation between sTNF-R55 and neopterin concentrations found in our study suggests that macrophages may be the major source of sTNF-R55 at it is the case for elevated neopterin levels. Moreover, endogenous interferon-gamma appears to be important to regulate expression and shedding of TNF-Rs.
Serum Neopterin in Chimpanzees
Eder G , Wachter H , Fuchs D Hans Popper Primate Center Immuno AG, Orth/ Donau, Austria; and Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria Thus far, three distinct studies examined neopterin concentrations in non-human primates, all of them deal~ng with simian immunodeficiency virus (SIV) infection. In one study neopterin concentrations were determined in serum and cerebrospinal fluid of D-retrovirus infected Rhesus macaques. In the healthy control animals (n=7) a mean value of 17.5 nmol/l neopterin in serum (S.D.± 4.4 nmol/l) was obtained using HPLC and measuring total neopterins after oxidative pretreatment of samples (1) . There was no significant difference between healthy controls, simian AIDS, simian AIDS-rea ted complex or carriers. In a second study using a competitive quantitative RIA, mean value of serum neopterin concentration of 2.0 nmol/l (S.D.± 1.0 nmol/l) was found in healthy juvenile macaques (2) . After infecPteridines / Vol. 4 I No.2 tion with SIV a marked increase of neopterin levels was observed in the animals. In a third study, a significant rise of neopterin concentrations shortly after SIV infection was also observed in urine samples (3). There was a clear-cut correlation amog positive PCR signal, virus isolation, neopterin increase and seroconversion.
Unlike Rhesus macaques, chimpanzees are susceptible to HIV-l but not to SIV. To investigate, if elevated serum neopterin levels in chimpanzees may be useful as an indicator of HIV-l infection, we established normal values and confidence limits. Two groups of chimpanzees were tested for serum ncopterin by RIA (Henning, Berlin Germanny), I group consisting of 17 animals 3-5 years of age that were imported from the wild in 1986. Shock-frozen serum samples were obtained after arrival in Vienna and during the following months, and they were tested retrospectively. Serum neopterin values of this group were compared with the results of a study which was initiated 6 years later (1992). The second group consisted of 5 animals, and blood samples were taken at biweekly intervals during a period of 5 months. Data from the first group showed non-normal distribution (Kolmogorov-test) with a median of 6.8 nmol/l, the 95% percentile was 16.3 nmol/l. Data from the second group showed a normal distribution with a mean value of 6.8 nmol/l (S.D.± 2.1 nmol/l) and a cut-off of 11.0 nmol/1. Four chimpanzees, three of them infected with HIV isolate HIV-I-MM-l were followed up twice a month for serum neopterin concentration for one year. A sharp rise in serum neopterin and consistently elevated serum neopterin values could be observed only in one of two infected chimpanzees. The P2 visual evoked response in man has a cholinergic component with the P100 response has not. The P100 latency is significantly decreased after an oral dose of phenylalanine in man while the P2 signal is unaffected. Analyses of the P100 decrease shows no correlation with tyrosine levels but a sifni-ficant positive correlation with plasma and urine total biopterin and neopterin levels. A small group shows a PlOO delay which correlates with increased neopterin levels only.
Increased plasma total biopterins in man following a phenylalanine dose are due to rapidly increased tetrahydrobiopterin synthesis in the liver.
Immune Activation during and after an Alpine Tour There is some evidence for immunological deterioration as a result of surgery (I). However, the changes of the cellular and humoral immune system after operations are not very well defined.
During the past years neopterin was demonstrated to be a sensitive marker of the cell-mediated immunity (2) . In the present investigation the influence of gynaecological routine operations on urinary neopterin concentrations were studied. A total of 24 patients (13 women undergoing abdominal hysterectomies, 1 women after laparoscopies) were followed before surgery and thereafter in daily intervals. After abdominal hysterctomies the median urinary neopterin concentrations showed a statistically significant increase (p<O.Ol, Wilcoxon paired rank test) from 165 (day before operation) to 248 micro mol/mol creatinine (day 3 after operation). Compared to pretherapeutic values, from day 2 until day 9 after operation neopterin concentrations remained significantly higher (p<O.Ol).
The median haemoglobin values decreased postoperatively from 145 (day before operation) to 117 giL (day 7 after operation). Neopterin concentrations measured on day 4 after abdominal hysterectomy showed a significantly inverse correlation with the haemoglobin values determined on day 4 after operation (p<O.OO5 Spearman rank).
After laparoscopies the median urinary neopterin concentration showed a significant increase from 108 (day before operation) to 172 micro mol/mol creatinine (day 3 after operation).
Increases of urinary neopterin after abdominal hysterectomies and laparoscopies provide evidence for activation of cell-mediated immunity after surgery. Furthermore, the inverse correlation of neopterin concentrations measured on day 4 with haemoglobin values determined on day 7 suggests an inhibitory influence of the activated cellular immune system on haematopoiesis. Neodrosopterin is one of the orange-red coloured pigments which were found in the eyes of the fruit fly Drosophila melanogaster. The structures of the well known drosopterins are shown above. For the structure of neodrosopterin we suppose that RI and R2 are just inverted with respect to the aurodrosopterin molecule. In order to confirm our proposal, we are synthesizing neodrosopterin chemically so that we will be able to compare our compound with the naturally occurring neodrosopterin.
In the flies drosopterin arises from 7,8-dihydropterin and 6-acetylhomopterin. The preparation of 7,8-dihydropterin is described in the literature. The 6-acetylhomopterin was synthesized for the first time by Boyle et al. (J. Chern. Soc., Perkin Trans I, 1990, 2071) Our primary target is to synthesize the corresponding 6-acetylhomolumazine. To accomplish this, we are proceeding in analogy to Boyle's strategy. Our starting compound is 6-chlorouracil. In contrast to Boyle's method, we have to introduce a protecting group in position one to avoid an unintentional ring closure. We succeeded in introducing the benzyloxymethyl group, which can be cleaved under acidic conditions just like the acetal moiety.
The nitration of the protected 6-chlorouracil without loss of the protecting group will be diffucult, as nitrations are usually carried out under strongly acidic conditions. Therefore we had to search for another possibility to introduce an amino group in position five. We decided on azocoupling, because the azogroup can be reduced to the aminogroup under the same conditions as the nitro group.
Instead of the "Boyle-amine", which is sythesized in five steps, we first made experiments with n-butylamine. To get the l-benzyloxymethyl-6-butylamino-5-phenylazouracil, we first condensed the 6-chlorouracil derivative with the n-butylamine and then carried out the azocoupling under mildly basic conditions. In the next time we will substitute the n-butylamine by the "Boyle-amine" hoping that this one reacts in the same way like the alkylamine. Preeclampsia is a pregnancy induced hypertensive disease with an incidence of about 5% in primigra-. vida and, being common, it significantly contributes to maternal and 1}eonatal morbidity and mortality. The primary cause remains unknown but might be immunologic, since immunologic aberrations are described in preeclampsia. Our previous studies have shown that complement, neutrophils and macrophages are activated in preeclampsia. The pathologic manifestations, and thereby the clinical findings in preeclampsia, may be explained by complement activation, resulting in the direct vascular effects of biologic active complement components and complement mediated activation of leukocytes, with the release of potent inflammatory mediators. The present study evaluated whether the extension of the macrophage, the neutrophil and the complement activation is related to the severity of preeclampsia. General vasospasm and microvascular injury are fundamental findings in preeclampsia, the degree of these findings follow the severity of the disease. The clinical conditions in preeclampsia differs, from women with moderate hypertension concomitant with proteinuria, to women with hypertensive crisis and the syndrome of hemolysis, elevated liver enzymes and low platelet count (HELLP syndrome). The only definite cure so far has been delivery, even in early pregnancy, with fatal consequences for the fetus. The main problem has been the lack of safe monitoring of women with severe preeclampsia in early pregnancy, gestational week 24 to 30, in order to predict lethal/serious deterioration in the maternal condition, may be leading to prompt deliveries in too many cases. The problem is delicate, but safe monitoring of women with severe preeclampsia is an essential issue in obstetrics and intensive care medicine.
Methods: Women with preeclampsia and patients with severe preeclampsia, complicated by the HE-LLP syndrome were studied. Women with uncomplicated pregnancies were controls. To detect activation of macrophages and polymorphonuclear (PMN) neutrophils, respectively, the formations of neopterin and PMN elastase were analyzed. For evaluation of complement activation, the biologically active components C5a and the tenninal C5b-9 complement complex (TCC) were detennined in plasma.
Results: Patients with the HELLP syndrome had significantly elevated plasma concentrations of neopterin and C5a at delivery as compared to women with preecrampsra, and as compared to are controls the HELLP group had significantly raised plasma levels of neopterin, PMN elastase, C5a and TCe. Women with preeclampsia had significantly higher plasma concentrations of neopterin and Tce at delivery as compared to the controls. In preeclamptics and HELLP patients, the plasma concentrations at delivery of PMN elastase, C5a and TCC were normalized within one week. but the plasma levels of neopterin remained elevated after one week.
Conclusions: Neopterin, PMN elastase, C5a and TCC are all raised in women with severe preeclampsia complicated by the HELLP syndrome. To monitor patients with preeclampsia by plasma concentrations of these parameters might therefor the helpful tools in predicting complications of the disease. According to the results of this study, neopterin could be the most sensible plasma parameter to follow.
The Case for Aluminium as the Neurotoxin in Sporadic Alzheimer's Disease
Hodgkins P, Blair JA Armstrong R Phannaceutical Sciences, Aston University, Binningham
The flash-plattem evoked potential difference (F-P) in man increases with age (93 subjects) correlates with decreasing cognitive ability and when it exceeds a unique critical value the subject is clinically diagnosed as having Alzheimer's disease. Aluminium accumulates in the human brain with age, increases the (F-P) value up to close on the critical value in a dose dependent way and at such a rate that nonnal environmental exposure to aluminium account" for all or nearly all the (F-P) increases in man. Aluminium neurotoxicity is therefore a major cause of sporadic Alzheimer's disease. , and a test prototype (9 patients; 32 implants) were used for reconstruction and patients were controlled till the re-entry operation. Neopterin levels were measured on day 0 (before operation) and then on the first, third, fifth, seventh, ninth, elevanth and thirteenth day after implantation. Till the reentry operation samples were taken weekly. At the same time anamnesis was taken in order to exclude acute or chronic disease. Articain-hydrochlorid 40 mg. Epinephrine-hydrochlotid 0.012 (Ultracain Dental Forte. 2 ml, Hoechst, FrankfurtlMain, GFR), was given for anaesthesia to all of them. All patients received antibiotic therapy for four post-operative days: 3-times a day Amoxicilline-trihydrate 500 mg and Potassium-clavulanat 125 mg (Augmentin 625, Beecham heppiginies, Belgium). All implantations were associated with a subsequent raise of neopterin levels from the first to the fifth day which was followed by a decrease. The average baseline neopterin levels were 160 umol/mol creatinine, the maxima 220 umol/mol creatinine. This increase of neoptclin levels may be due to tissue damage and trauma after operation. In case of Branenmark and IMZ implantation a second raise of neopterin levels was observed later on. The degree of increase was similar to the primary peak. In contrast, the test prototype implant showed a different behavior: Neopterin concentrations decreased to nonnal without a second increase. The difference of post implantation neopterin courses seems to be due to the atraumatic drilling system used in the latter type of implants. All patients are under control now, and a life time analysis will show if there are difference regarding outcome which are due to the drilling systems used. In the HIV positive group 14 of 15 patients (93%) had elevated serum neopterin levels when TB was diagnosed (mean± sem: 22.1 ± 2.7 nmol/l). Similar values were found in the HIV negative group (20.5± 3.3 nmol/l, 83% with elevated levels). At the end of antituberculous treatment both groups showed significantly lower neopterin concentrations (l2.4± 1.7 nmol/l in HIV positives, p<0.OO5; lO.l± 2.8 nmol/l in HIV negatives, p=0.02). The median value for HIV negative patients laid within normal range (6.8 nmol/l) whereas it remained raised in HIV positive individuals (9.5 nmol/l).
Changes in Serum Neopterin
Neopterin concentrations in our patients did not correlate with the extent of pulmonary lesions according to radiological findings (number of zones involved, presence of cavities) but were associated with disease activity (e.g., fever, anaemia, acute phase reactants). Patients with normal neopterin levels at the end of treatment were more likely to remain well during the follow-up period of 12 months. In both HIV positive and HIV negative patients neopterin could be used as biochemical indicator to monitor the clinical response to antituberculous treatment. The structural relationship between the purine-sys-
tern of adenine on the one side and the pteridinesystem of 4-amino-7-(8H)-pteridinone on the other side, gave us the idea, to synthesize a pteridine-nucleo side which could be called 'ptero-2'-deoxy-adenosine' and which is analogous to the natural nucleoside 2' -deoxy-adenosine.
2' -deoxy-adenosine ptero-2' -deoxy-adenosine R1 :H.C 6 H S R2 = H, C 6
HS
We would like to modifY this pteridine-nucleoside in a way to make it useable for oligonucleotide syntheses. This means exactly, to protect the 5' -hydroxyfunction with 4,4' -dimethoxy-triphenylmethyl-chloride and then to synthesize the 3' -phosphitamide. So we get a building-block which we could introduce into DNA instead of the natural 2' -deoxy-adenosine using the modem phospho rami tide method. Mter introduction of the pteridine-nucleoside, we will look for an a-helix formed by base-pairing as it was postulated by Watson and Crick or if any antiviral or antibacterial activity is exhibited. One could use this pteridine-nucleoside also as a marker in DNA-analyses instead of radioactively marked nucleosides, because under UV-light one can observe fluorescence due to the pteridine-base. Fluorescence has the great advantage over radioactivity because it is harmless.
For this purpose we synthesized the 4-amino-7(8H)-pteridinone and its 2-and 6-phenyl derivatives, from which we expected a better solubility in organic solvents. For a direct glycosylation of these bases we had a problem. We wanted to selectively glycosylate at the N8-position but we had two reactive centers in the molecule, the nitrogen in the number 8-position and the 4-amino-group. So we had to look for a protective group for the amino-function to prevent glycosylation at this position. A protective group which would be stable under glycosylation conditions and which could be easily cleaved.
Conversion with N,N-dimethylformamide-diethylacetale in DMF to the corresponding amidines was well suited to our compounds and we got them in high yields.
These protected heterocyclic bases have to be silylated for good solubility by heating with excess hexa-methyl-disilazane (HMOS) to the corresponding silyl-derivatives. Glycosylation of the silylated bases with 3,5-di-O-( 4-chloro-benzoyl)-I-chloro-2-deoxy-ribofuranose was carried out in acetonitrile in the presence of the Friedel-Crafts catalyst stannic (IV) choride. Two glycosylation products were formed, the l3-anomer and the a-anomer, with the desired 13-anomer as the major product. They were seperated by column chromatography with the l3-compound exhibiting faster migration.
In order to discriminate hetween a-and l3-anomers IH-NMR can be used. Previous experience has shown that the 2' -hydrogens on a l3-substituted nucleoside come into resonance relatively far apart. Conversely the 2' -hydrogens on an a-sub situ ted sugar lie fairly close to one another. This method works well, but to be absolutely sure, furtherNMR-manipulations are necessary e.g. NOE-experimentes. Interferon gamma (lFN gamma) has been shown to have multiple immunoregulatory properties. The production of interferon gamma stimulated by endotoxin is known to be a criterion in active immunological response. Interferon gamma interferes regulatorily in inflammatory processes acting as an antagonist of the cytokines IL-I and IFN which are also iniciated to be released by endotoxin.
During the initial stage of immune reaction interferon gamma is stimulating pteridin synthesis in mononuclear phagocytes. Synthesis of pteridines like biopterin be regarded as a criterion in activation of monocytes or macrophages indicated by endotoxin. Our study was designed to investigate the activation of immunomechanisms by septicemia, caused by peritonitis in Wistar-Prag albinorats. 6 hours after intraperitoneal administration of a defined Escherichia coli-hemoglobin suspension (1010 germs/ml and antologous blood) the level of endotoxin was determined with a chromogenous limulus test:, and synthesis of interferon gamma as well as release of the pteridine biopterin were analysed by enzymeimmunoassay respectively radioimmunoassay. Compared with a control group treated with sterile saline solution significant differences were found with all measured parameters. The life-long production of granulocytes, monocytes and other blood cells depends on a continous supply of bone marrow progenitor cells capable of differentiating along any of several lineage-specific pathways. Although still incomplete, our understanding of blood cell production is now more advanced than ever before. We have learned that the mechanism by which bone marrow elements develop to mature blood cells is mediated and regulated by humoral agents. Granulocyte-colony-stimulating-factor (G-CSF) stimulates specifically differentiation of neutrophils whereas granulocyte-macrophage-CSF (GM-CSF) excerts a broader action and stimuates in addition to neutrophilic ones other types of granulocytes too and also macrophages/ monocytes. Both substances are now used in the treatment of chemotherapy induced neutropenia, because this is one of the most important and dose limiting side effect of cancer treatment. Febrile complications and sepsis are therefore common and often life threatening.
In a non-random fashion 37 patients with chemotherapy induced neutropenia were treated with 300 fJg of G or GM CSF s.c. until a normal white cell count was restored.
At start of therapy number of white cells in peripheral blood was not distinguishable for both groups of patients (2.1 vs 2.2 G/l). G and GM CSF were equally able to to induce a rapid recovery of white cell count within one or two days. For a better understanding of the activity of these substances we measured also neopterin excretion. In G-CSF treated patients only a marginal induction of neopterin was observed. On day 4 the mean value was about 40% above the basal level. On the other hand GM-CSF treated patients were characterized by a more than 2 fold increase in urinary neopterin levels (p<O.01).
To clarifY the mechanism of this induction THPI cells were treated with either G or GM CSF (10 ng/ml). Both substances did not alter the spontaneous neopterin release whereas treatment with IFNgamma (10 ng/ml) led to a marked increase in neopterin production. The addition of GM-CSF but not G-CSF significantly augmented neopterin hiosynthesis. This effect was accompanied by a marked acceleration of IFN-gamma induced tryptophan degradation to kynurenine by GM but not by G-CSF. Indicators of the acute phase response are known to be elevated in acute pancreatitis. Recently, an elevation of circulating interleukin-6 levels has heen reported to correlate with the prognosis of this disease. We have measured urinary neopterin excretion, which is postulated to reflect the systemic activity of another cytokine, interferon-gamma,in 3 patients, 2 males and I female, aged 24, 41 and 58 years, respe~tively, presenting with an attack of acute pancreatitis. Urinary neopterin was found to be increased in all three (405, 309 and 548 umol/mo creatinine, respectively). We followed the time course of urinary neopterin excretion in 2 patients. Both had experienced an increase in urinary neopterin during the course of their disease from values in the normal range (167 and 169 umol/mol creatinine) to the respective peak values of 309 and 548 umol/mol creatinine.
These results indicate, that immune system activation may not he limited to monocyte derived cytokines like interleukin-6, but activation ofT cells, believed to be the main source of interferon-gamma, could also be involved. FUlther study is warranted to determine the extent and prognostic significance of elevated urinary neopterin in acute pancreatitis. Urinary zinc excretion is known to be elevated in a variety of disorders, including cancer, infections, or burns. All of these conditions are characterized by the activation of the immune system, which is reflected by elevated circulating cytokine levels. The systemic activity of some cytokines can be estimated by their metabolic effects. Urinary neopterin is known to reflect mainly interferon-gamma levels. In order to investigate the possibility of a linkage between the immune system activation and urinary zinc excretion, we measured urinary zinc levels in 70 non-selected consecutive patients with diagnoses including, among others, malignant tumors, systemic lupus erythematosus, inflammatory bowel disease, hyperthyroidism and cirrhosis, in whom neopterin determination was ordered for assessment of the systemic immune activition. The mean urinary neopterin and zinc excretion in 17 patients with malignant tumors was 635± 518 umol/mol creatinine and 2.31± l.99 mmol/mol creatinine. There was a significant correlation (Spearman's coefficient, rs=0.587, p<O.OI) between the two variables. Interestingly, this correlation was preserved even if we evaluated the respective values of the whole patient population (r5 = 0.4465, p<O.OI).
These results indicate that immune system activation reflested by increased urinary neopterin leveis may be involved in inducing elevated zincuria. Some cytokines, like interleukin-l , are known to effect functioning of renal tubuli, which, in its turn, are essential in regulating renal zinc handling.
We conclude that the measurement of urinary zinc may provide another possibility for assessment of the cytokine system activation. The lymphocyte subsets are significantly different according to the initial post transplant immunosuppression. As shown ATG treatment is associated with a marked decrease in the C04/ CD8 ratio (0.6 SO 0.4, n = 37) and corresponding increase in the C08 +-HNK 1 +-subset (365 SO 310, n=36). The neopterin increases in the ATG group are not statistically significant whereas UNEOP is discriminating between patients with and without serologically diagnosed CMV infections (506 SO 475, n=44 in contrast to 341 SO 242, n = 55). The acute phase reactant SAA does not show a typical pattern for different treatment groups nor for CMV viral infections.
Conclusion: ATG treatment is not only causing acute but also characteristics long-term changes in lymphocyte subsets, persisting over years and indicating chronic active viral infections. In contrast significant long-term effects in UNEOP levels are seen in acute, serologically diagnosed CMV infections.
Neopterin as a Marker in Bone Infections
Peters KMI, Leusch HG 2 , Forst Rl IOrthopaedic Clinic, RWTH Aachen 2Institute of Medical Immunology, RWTH Aachen
Neopterin is a metabolite in the biosynthesis of tetrahydrobiopterin and is synthesized mainly in macrophages. Elevated levels of neopterin are related to activity in cell-mediated immune response and are found especially in viral infections. Neopterin is a useful marker for the screening of potential blood and spongiosa donors because neopterin levels are already elevated before HIV-antibodies are produced by HIV-infected patients. In our current study we wanted to evaluate neopterin as a marker for the detection and follow-up of bone infections
In patients with osteomyelitis of the limbs (n =40) and the spine (n= 12) the following biochemical markers were tester before starting a therapy and in follow up: neopterin, PMN elastase, C-reactive protein (CRP), fibrinogen, erythrocyte sedimentation rate (ESR) and leukocyte count (WBC). In 21 patients with non-inflammatory orthopaedic diseases (nucleus prolaps, conservatively treated fractures) we evaluated a "diagnostic specificity" of these markers.
Neopterin was measured by a radioimmunoassay (IMMU test Neopterin, normal range < 10 nmol/l), PMN elastase by an enzyme-linked immunoassay (IMAC-assay). CRP was determined n' ephelometically by Na-Latex-CRP-reagent. The determination of fibrinogen was done as described by Clauss. ESR was measured according to Westergreen. WBC was done automatically by Technocon H6000.
In patients with osteomyelitis of the limbs neopterin reached only a poor sensitivity of 26%. Sensitivity of the other markers was better: CRP 71%, PMN elastase 69%, ESR 89%. Only WBC reached a poorer sensitivity in bone infections (16%). In postoperative follow up of patients with osteomyelitis of the limbs . PMN elastase and fibrinogen showed the quickest normalization. 2-4 days postoperatively neopterin was still elevated only in 24% of the patients. 3 weaks after operation 16% had elevated neopterin levels in serum. Neopterin determinations were only of limited value in patients with bacterial infections of the long bones. But in patients with spinal infections (spondylodiscitis) results were different: Sensitivity of neopterin and CRP was 75% each. In 3 of 12 patients with histologically proven spondylodiscitis inflammation was only detected by elevated levels of neopterin and PMN elastase. The determination of neopterin, PMN elastase and CRP was also helpful in monitoring treatment of spondylodiscitis. In the course of treated spndylodiscitis they fell consistantIy into normal, whereas ESR was still elevated. For detection and clinical follow up of spondylodiscitis wer recommend combined detenninations of CRP, neopterin and PMN elastase.
In Recently, nitric oxide has been found to be released from neurons upon activation of glutamate receptors and to act as a neuronal messenger in the brain. A substantial role of the cofactor tetrahydrobiopterin in nitric oxide synthesis in the brain has also been proposed. Furthermore, tetrahydrobiopterin was shown to increase the release of various neurotransmitters by a still unidentified mechanism. Now the influence of nitric oxide and of the tetrahydrobiopterin precursor sepiapterin on acetylcholine release in the ventral striatum was studied.
The ventral striatum of conscious, freely moving rats was superfused through a push-pull cannula with artificial CSF containing 1 !lmol/l neostigmine. Acetylcholine in the superfusate was determined by HPLC combined with electrochemical detection. The experimental strategies included inhibition of nitric oxide synthase by superfusion with the irreversible inhibitor NG-nitro-L-arginine, with the nitric oxide donor SIN-I , with the inhibitor of guanylate cyclase methylene blue and with the tetrahydrobiopterin precursor sepiapterin.
Superfusion with NG-nitro-L-arginine (100 !lmol/l) caused a substantial decrease in activity of nitric oxide synthase of the striatum and decreased the release rate of acetylcholine by about 40% of basal release. Superfusion with SIN-l (200 !lmol/l) increased the acetylcholine release. Presuperfusion with methylene blue abolished the effect of SIN-} indicating that nitric oxide, produced from decomposition of SIN-I, acts via cGMP. Hence, it seems that in the ventral striatum nitric oxide is synthesized continuously and stimulates the release of acetylcholine from its neurons.
Superfusion with the tetrahydrobiopterin precursor sepiapterin also increased the acetylcholine release. This effect was reduced by presuperfusion with NGnitro-L-arginine. Thus, sepiapterin increases acetylcholine release via a mechanism which depends at least partly on nitric oxide synthesis.
Ab Initio Quantum Chemical Calculations on 6-and 7-Phenacetyl Pterin In order to investigate the stabilities of different tautomeric forms of pteridine derivatives with a phenacetyl side chain in the 6-or 7-position, we performed quantum chemical geometry optimizations of both the keto form and the vinylogous amide form 6-and 7-phenacetyl pterin. Since initial semi empirical calculations using the AM I and PM3 method were inconclusive, the ab initio hartree-Fock procedure was used, and the 3-2IG* basis set was employed for the calculations. The results are in accordance with experimental expectations: the keto form is slightly more stable for the 6-substituted deri\'atiw (1 .8 kcal per mol), while the vinylogous amide forn1 is substantially more stable for the 7-substituted compound (8.7 kcal per mol). The vinylogous amide forms are planar molecules, and this geometry enables the interaction between the hydrogen atom at N-5 (or N-8) and the carbonyl function of the side chain. Inspection of the calculated electron densities (population analysis) underlines the suggestion that the viylogous amide form of 7-phenacetyl pterin is stabilized by a shift of electron density from the nitrogen bonded to C-2 to the carbonyl oxygen atom of the side chain (resonance stabilization via an additional highly conjugated vinylogous amide structure).
Increased Neopterin in Carotid Atherosclerosis
Reibnegger Activation of T cells and macrophages may play a role in the pathogenesis and progression of atherosclerosis. In 561 subjects drawn from a community-based study, we compared serum concentrations of neopterin and soluble interleukin-2 receptors with routine laboratory variables, candidate risk variables and the degree of carotid atherosclerosis. The extent of carotid atherosclerosis was assessed by an ultrasound B-mode procedure based scoring system. All subjects, aged from 50 to 80 years, undeIWent detailed physical examination. Serum concentrations of neopterin, but not of soluble interleukin-2 receptors, in men and women with evident carotid atherosclerosis were significantly higher than in subjects without. Neopterin or the ratio between neopterin and creatinine were closely correlated with the atherosclerosis score. In univariate correlation analyses, neopterin was ranking highest of all laboratory variables with respect to its correlation with the score of carotid atherosclerosis. By multivariate linear discriminant analyses the statistically significant and independent association between neopterin and presence/ absence of atherosclerosis was confirmed: neopterin or its ratio to creatinine were invariably selected for inclusion into the multivariate models resulting from various analyses. Thus, the macrophagederived immune activation marker neopterin is closely correlated with the extent of carotid atherosclerosis. In accordance with other evidences, chronic immune activation of immune cells, preferentially of macrophages. may play a key role in atherogenesis and/or progression of atherosclerosis. Congestive heart failure (CHF) may induce hepatic congestion with structural and functional derangements. The critical pathogenetic factor appears to be hepatic hypoxia which causes centrolobular damage and influences hepatocytes and Kupffer cells (KC). Because KC are resident macrophages in the liver, activation of macrophages and its possible association with increasing serum neopterin levels and liver enzymes is of particular interest. The purporse of our study was to investigate the relationship between neopterin levels and results of other liver biochemical tests.
Serum Neopterin and Uver Funtion in Patients with
In our study, we examined 56 patients with CHF (25 with ch ronic myocarditis and 31 with dilated cardiomyopathy (DCMP), mean age 38± 11 years, mean NYHA class 2.3± 0.78). World Health Organization criteria were used for diagnosis of DCMP and chronic myocarditis. All patients were negative for hepatitis B antigen. Serum neopterin was measured with radioimmunoassay (Henning-Berlin, Ger-many). Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (AL T), alkaline phosphotase (ALP), bilirubin, cholesterol and triglicerides were determined by spectrophotometry using commercial kits (Beckman, USA).
Neopterin levels significantly correlated with activity of AST (r,=0.28 p<0.05), bilirubin (r 5 =0.40, p<O.OI) and cholesterol levels (r5= -0.32 p<0.02). In patients with DCMP neopterin correlated only with colesterol levels (r5= -0.48, p<O.OI) and in chronic myocarditis with AST and bilirubin (r5=0.65 and r5 = 0.54, p<O.Ol). In addition, we observed significant correlations between neopterin concentrations and clinical markers of severity of CHF: NYHA class (r,= 0.67, p<O.OOI), right ventricular diameter (r, =0.55, p<O.Ol), left ventricular ejection fraction (r, = -0.45, p<O.04).
The correlations found between increasing neopterin levels and markers of liver function in patients with CHF differs from results obtained in non-inflammatory liver diseases by other authors. We conclude that haemodynamic and metabolic disturbances in patients with CHF may be one underlying cause of immune activation in these patients. Systemic lupus erythematosus (SLE) is a mUltisystem autoimmune disease affecting a variety of tissues and organs. Abnomlalities of cell-mediated immunity in SLE have been described and play an important role. The aim of our study was to define possible associations between different markers of immune activation in patients with SLE.
In our study, we examined 33 SLE patients (30 females, 3 males, age 16-61 years) who fulfilled the American Rheumatism Associaion revised criteria for diagnosis of SLE. A modifed index of European Consensus Lupus Activity Measurement (ECLAM) was used for calculating SLE activity. Neopterin and
beta-2-microglobulin (beta2m) were measured with radioimmunoassay (Henning-Berlin, Germany and Pharmacia, Sweden, respectively) and soluble tumour necrosis factor receptors (sTNF-R) with an enzymelinked immunosorbent assay (T-cell Sciences, Cambridge, USA).
The Spearmen rank correlation coefficients with r, = 0.57 (p<O.OOI) and r, =0.48 (p<0.OO5) indicate connections of increasing neopterin or beta2m levels and ECLAM values. There were also significant correlations between neopterin or beta2m concentrations and erythrocytes sedimentation rate r, =0.33 (p<0.05) and r, =0.45 (p<O.OI). Significant correlations were observed between sTNF-R and neopterin (r, =0.85, p<O.OOI) or beta2m (r,=0.70, p<O.OOI). Interestingly, we found an inverse correlation between haemoglobin and neopterin (r5= -0.45, p<O.Ol) or sTNF-R levels (r, = -0.50, p<O.Ol).
We conclude, that chronic autoimmune inflammation in SLE is associated with enhanced endogenous release of cytokines which, in tum, induce formation of neopterin and beta2m. Neopterin or beta2m may be useful as independent markers of disease activity in SLE. Our data also indicate a role of immune activation in the pathogenesis of anaemia in SLE patients.
Comparative It was the objective of the study to scrutinize monocyte (M<P) behaviour under stressful conditions by comparing in-vitro NPT synthesis with proinflammatory cytokine production Peripheral blood mononuclear cell cultures (PBMC) from 14 severely traumatized patients and 10 patients suffering from a major septic episode on the days 1, 3, 5, 7, 10 after trauma or following the first onset of sepsis were prepared and stimulated with the mitogen phytohemagglutinin (PHA) to induce NPT release respectively with LPS to induce the release of IL-/3, IL-6, IL-8 and TNF-a. We have seen a significant elevation of in-vitro NPT release in the cummulative data of both patient groups compared to healthy controls. When discriminating the NPT release per individual CDI4 + M<j> it was found only the M<j> in septic patients but not in the trauma population arc characterized through a significant elevation of NPT release.
Analyzing the NPT release profiles in the individual trauma patient, we saw, primarily due to monocytosis, supranormal levels during the posttrauma course with a tendency to normal values at the end of the obselvation time. The individual profiles in the sepsis population were much more heterogenous. Interestingly, it was found that a sudden breakdown of NPT production following a previous increment of NPT release appears to be a sensitive indicator for later lethal outcome. Comparing the NPT levels with the synthesis patterns of the proinflammatory cytokines studied, we could not find any c1earcut correlation bctween cytokine secretion and the degree of metabolic M<j> activation. On the other hand there was a good intercorrelation between the profiles of the individual cytokines in the majority of patients. In further prospective studies it will be investigated wether there is a correlation between the in-vivo NPT serum levels and the ex-vivo NPT release from stimulated M<j> cultures, in order to get further information as a predictor of outcome and complication rates in patients undergoing major surgery. Urine neopterin was analysed in 22 severe preeclamptic patients (14 with HELLP syndrome) and 20 healthy pregnant controls (matched for age and gestational age) before delivery and on each of the fivc postpartum days.
Markers of macrophage activation (lL-l, IL-6. TNFalpha, neopterin) in plasma were analysed in 37 patients with hypertensive disorders of pregnancy (5 with pregnancy-induced hypel1ension, 20 with preeclampsia, 10 with HELLP-syndrome, 2 with eclampsia). The control group consisted of 10 healthy pregnant women and 10 healthy nonpregnant women.
Results: The prepartal urine neopterin median in preeclampsia (337 f..lmol/mol creal.) was 33% higher than that of healthy pregnant controls (253 f..lillol/ mol creal.). Concommitantly with clinical improvement of preeclamptic patients neopterin medians became indistringuishable from those of the control group.
In plasma there wcre no statistical significant differences in cytokine concentrations between healthy pregnant and non-pregnant controls with the exception of neopterin, that showed higher values in pregnant women (p=O.OO4). Elevated levels of IL-6, TNF-alpha and neopterin were observed in hypertensive women. Differences to healthy pregnant controls were statistically significant for IL-6 (p=O.OO8). TNF-alpha (p=0.OO9) and neopterin (p=O.OO4) and were more pronounced in severe forms of the disease. These three parameters of monocytic origin showed positive significant correlations amongst each other. A participation of macrophages in the pathomechanism of hypertensive disorders of preg: nancy can thus be assumed. Compared to healthy controls serum neopterin concentrations were significantly increased in the groups with the leucaemic variant of CTCI and patients with stage IB and stage IV of CTCL, however patients with premycotic CTCL and isolated forms (T 1) did not show serum neopterin leels different from controls. The highest values were seen in patients with stage IV of disease, in particular patients with tumors consisting of large, anaplastic lymphocytes. These patients also suffered from anaemia, weight loss and fever and died within months despite therapy.
Serum Neopterin in
In contrast to haematological B-cell lymphoma (centrocytic-centroblastic NHL), cutaneous B-cell lymphoma did not sow elevated serum neopterin levels, even not in high grade cutaneous B-cell lymphoma with large lymphocytes. All of these patients are still alive without any disease activity. We conclude that cutaneous T cell, but not B-cell lymphoma activates cellular immunity and release of cytokines such as interferon gamma. Dedifferentiation of CTCL into large cell anaplastic lymphoma is associated with massive neopterin production induced by endogenous cytokine release which may be responsible for the distinct clinical symptoms. High grade cutaneous B-cell lymphoma are more localized and therefore probably not capable of inducing systemic immun activation. Our studies also confirm the data that neopterin concentrations represent a prognostic marker. 6-and 1.3.7-trimethyl-lumazines with various aliphatic, aromatic and heterocyclic aldehydes, respectively, led in high yields to the corresponding vinyl derivatives (l). Bromine addition to the ethene function in 2-(1.3-dimethyllumazin-6-and 7-yl)-styrene aswell as methyl 2-(1.3-dimethyllumazin-6-yl)-acrylate proceeds at room temperature almost quantitatively to form the erythro-dibromo deivatives.
Treatment of 6-(l,2-dibromo-2-phenylethyl)-1,3-methyllumazine (1) with nucleophiles such as sodium methoxide in MeOH, DBU in EtOH, sodium hydroxide in EtOH and ammonia in dioxan does not lead to simple elimination or displacement reactions in the side-chain but attacks the system at the vinylogous C-7 position to form the corresponding 7-sub-stituted 2-(1.3-dimethyllumazin-6-yl)-styrenes (2) (3) (4) (5) . DBU in dioxan, however, converted 1 in the expected manner into 1-(1.3-dimethyllumazin-6-yl)-2-phenyl-acetylene (6). A most interesting reaction takes place with 1 and methyl 2-(l.3-dimethyllumazin-6-yl)-I.2-dibromopropionate (7), respectively, on treatment with DBU in dioxan forming a complex new condensed heterocyclic ringsystem (8,9) consisting of five nitrogen-heterocycles.
Finally it was found that the 7-(1. Dihydropteridine reductase (DHPR:NAD(P)H: 6,7-dihydropteridine oxidorelductase, EC 1.6.99.7) catalyses the reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin using NADH as a cofactor. The structure of a binary complex of DHPR with its cofactor, isolated from rat liver, has been solved from an orthorhombic C222 1 crystal form to a final R factor of 15.4% using 2.3A diffraction data. The enzyme exhibits an a/13 structure with a Rossman-type dinucleotide fold for NADH binding and dimerisation is mediated by a four-helix bundle motif with two helices from each monomer. The rat enzyme sequence shows little difference from that of the human enzyme therefore the crystallographic structure can be used to interpret specific mutant changes reported for DHPR samples isolated from patients exhibiting symptoms of aberrant PKU. 3-Hydroxy anthranilic acid can be formed from kynurenine by two routes: The classical pathway, which involves first a hydroxylation of kynurenine to 3-hydroxy kynurenine, followed by cleavage to 3-hydroxyanthranilic acid and an alternative pathway, in which kynurenine is first cleaved to anthranilic acid, which is then hydroxylated to 3-hydroxy anthranilic acid. Indications for the alternative pathway were found by formation of 3-hydroxy anthranilate from anthranilate in rat liver (1) and rat brain (2) . A tetrahydrofolate dependent anthranilate 3-monooxygenase had been purified from the leaves of Tecoma slans (3) We investigated formation of 3-hydroxy anthranilate from anthranilate in presence or absence of a tetrahydropteridin in homogenates of human A-498 kidney carcinoma cells, rat brain and rat liver by high performance liquid chromatography. Protein fractions were prepared by Sephadex G-25 chromatography and incubated in presence of NADH, NADPH, anthranilate or kynurenine and with or without 6,7-dimethyl tetrahydropterin at 37°C for 0 to 60 minutes. Our results indicate that the tetrahydropterin supports chemical hydroxylation of anthranilic acid and that in homogenates of A-498 cells 3-hydroxy anthranilic acid is formed from kynurenine by the classical pathway without the requirement of a tetrahydropteridien. In rat liver and rat brain, the enzyme activites were found to be lower, thus approaching the range of chemical hydroxylation of anthranilate. Further work will therefore ge required to clarify the route of 3-hydroxy anthranilate formation in these tissues. Pteridines are pyrazino-pyrimidine compounds synthesized by cleavage of guanosine triphosphate and released by human monocytesl macrophages after stimulation by interferon-gamma. Their concentrations in various body fluids proved to be indicative of the current status of the cellular immune system and determination of pteridines has become an important diagnostic tool. The present study has been perfoemed to identify cellular effects of pteridines on human monocytic cells with characteristics of macrophages (THP-l cells). Since an increase of intracellular calcium concentration plays a certain role in the activation of macrophages, the effect of pteridines on the intracellular calcium concentration has been evaluated. To this end, dual wavelength fura-2 fluorescence has been determined in single THP-1 cells fixed on poly-lysine coated cover glasses in both, the absence and presence of neopterin (N), 7,8-dihydroneopterin (NH2) and 5,6,7,8-tetrahydrobiopterin (BH4). All three substances tested lead to a rapid, transient increase of intracellular calcium concentration in THP-l cells. Significant increases of intracellular calcium are observed at 10 nmol/I NH2, at 100 nmolll BH4, and at 1 flmol/I N, i.e. at concentrations encountered in vivo. At a concentration of 1 flmol/l intracellular calcium concentration was transiently increased from a control value of 140± 25 nmolll to 464± 62 nmolll (NH2), 340± 41 nmolll (BH4), and 344± 45 nmolll (N), respectively. Absence of extracellular calcium or presence of lanthanum ions (0.1 mmolll), known to block certain calcium channels, fully reverses the pteridine-induced increase of intracellular calcium, indicating utilization of calcium from the extracellular space possibly via activation of of a lanthanum-sensitive calcium channel. In conclusion, pteridines seem to be involved in the crosstalk of immune competent cells and may possibly be able to modulate effects of inflammatory substances on monocytic cells. Among other diseases, increased concentrations of neopterin in body fluids have been described in cer-
